Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Key Metrics
as of Sep 2026
Market Cap 4,487 Cr
P/E 38.40
Div Yield 0.88 %
Book Value βΉ366.00
52w High βΉ3,082.00
52w Low βΉ1,731.00
Face Value βΉ8.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
196.00
177.00
180.00
182.00
169.00
143.00
173.00
172.00
165.00
127.00
154.00
154.00
148.00
Expenses
152.00
144.00
140.00
143.00
133.00
118.00
124.00
126.00
126.00
106.00
116.00
116.00
116.00
Operating Profit
44.00
33.00
40.00
39.00
35.00
25.00
49.00
46.00
39.00
21.00
38.00
37.00
32.00
OPM %
22.00
19.00
22.00
21.00
21.00
18.00
28.00
27.00
24.00
16.00
25.00
24.00
22.00
Other Income
4.00
13.00
-5.00
16.00
5.00
115.00
3.00
-25.00
2.00
2.00
2.00
2.00
2.00
Depreciation
6.00
6.00
5.00
5.00
5.00
5.00
5.00
5.00
5.00
4.00
4.00
4.00
4.00
Interest
1.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit before tax
41.00
40.00
29.00
49.00
35.00
135.00
47.00
15.00
36.00
18.00
36.00
35.00
30.00
Tax %
26.00
26.00
24.00
25.00
26.00
13.00
26.00
72.00
26.00
25.00
26.00
26.00
26.00
Net Profit
31.00
30.00
22.00
37.00
26.00
117.00
35.00
4.00
27.00
13.00
26.00
26.00
22.00
EPS in Rs
18.48
18.08
13.38
22.28
15.90
70.95
21.12
2.54
16.18
8.01
16.00
15.64
13.36
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
708.00 653.00 582.00 513.00 440.00 389.00 376.00 330.00 344.00 294.00 279.00 242.00
Expenses
560.00 493.00 453.00 408.00 353.00 318.00 315.00 296.00 306.00 274.00 256.00 228.00
Operating Profit
148.00 161.00 129.00 104.00 87.00 71.00 60.00 34.00 38.00 20.00 23.00 14.00
OPM %
21.00 25.00 22.00 20.00 20.00 18.00 16.00 10.00 11.00 7.00 8.00 6.00
Other Income
29.00 95.00 7.00 4.00 3.00 1.00 -5.00 1.00 1.00 18.00 1.00 1.00
Interest
2.00 2.00 1.00 1.00 1.00 2.00 3.00 5.00 5.00 4.00 2.00 3.00
Depreciation
21.00 21.00 17.00 16.00 16.00 16.00 16.00 15.00 14.00 11.00 10.00 11.00
Profit before tax
154.00 233.00 118.00 92.00 73.00 54.00 36.00 15.00 20.00 23.00 12.00 1.00
Tax %
25.00 21.00 26.00 26.00 30.00 25.00 20.00 28.00 34.00 10.00 0.00 0.00
Net Profit
115.00 183.00 88.00 68.00 51.00 40.00 29.00 11.00 13.00 21.00 12.00 1.00
EPS in Rs
69.64 110.79 53.00 40.90 31.13 24.19 17.54 6.54 8.13 12.70 7.03 0.60
Dividend Payout %
34.00 22.00 30.00 29.00 31.00 30.00 23.00 37.00 30.00 22.00 23.00 132.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00 13.00
Reserves
592.00 517.00 362.00 294.00 243.00 203.00 163.00 147.00 142.00 134.00 120.00 112.00
Borrowings
20.00 0.00 0.00 0.00 1.00 2.00 12.00 36.00 54.00 45.00 23.00 33.00
Other Liabilities
168.00 127.00 138.00 112.00 88.00 85.00 78.00 54.00 82.00 55.00 49.00 39.00
Total Liabilities
793.00 658.00 513.00 419.00 345.00 303.00 267.00 251.00 291.00 247.00 205.00 197.00
Fixed Assets
197.00 172.00 114.00 124.00 104.00 113.00 123.00 128.00 131.00 137.00 109.00 105.00
CWIP
23.00 16.00 96.00 25.00 31.00 12.00 10.00 17.00 9.00 2.00 2.00 1.00
Investments
120.00 127.00 91.00 58.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
454.00 343.00 212.00 211.00 210.00 178.00 134.00 106.00 152.00 108.00 94.00 92.00
Total Assets
793.00 658.00 513.00 419.00 345.00 303.00 267.00 251.00 291.00 247.00 205.00 197.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
56.00 78.00 94.00 91.00 65.00 58.00 50.00 46.00 15.00 7.00 33.00 -2.00
Cash from Investing Activity
51.00 -42.00 -79.00 -106.00 -35.00 -8.00 -11.00 -19.00 -16.00 -30.00 -15.00 -10.00
Cash from Financing Activity
-21.00 -27.00 -20.00 -17.00 -14.00 -10.00 -39.00 -26.00 0.00 23.00 -18.00 12.00
Net Cash Flow
87.00 9.00 -5.00 -32.00 17.00 40.00 0.00 0.00 -1.00 1.00 0.00 0.00
Free Cash Flow
-9.00 151.00 25.00 58.00 41.00 50.00 39.00 26.00 -1.00 -48.00 18.00 -12.00
CFO/OP %
63.00 81.00 96.00 111.00 96.00 94.00 94.00 144.00 48.00 58.00 150.00 14.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
60.00 48.00 31.00 27.00 27.00 54.00 62.00 43.00 72.00 49.00 48.00 61.00
Inventory Days
179.00 159.00 200.00 203.00 214.00 162.00 133.00 136.00 171.00 163.00 156.00 149.00
Days Payable
141.00 135.00 140.00 138.00 117.00 132.00 127.00 83.00 165.00 102.00 135.00 109.00
Cash Conversion Cycle
99.00 72.00 90.00 91.00 124.00 84.00 68.00 96.00 78.00 110.00 70.00 101.00
Working Capital Days
64.00 45.00 25.00 33.00 47.00 52.00 41.00 20.00 22.00 20.00 26.00 27.00
ROCE %
26.00 33.00 35.00 33.00 31.00 27.00 23.00 10.00 13.00 10.00 9.00 2.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.95
72.95
72.95
72.95
72.95
72.95
72.95
72.82
72.82
72.82
72.82
72.82
FIIs
0.95
0.87
1.00
1.11
1.35
1.46
1.30
1.35
1.15
0.90
0.56
0.46
DIIs
8.68
7.45
7.04
6.70
6.49
6.14
6.06
5.45
2.61
2.16
1.77
1.57
Public
17.42
18.72
19.01
19.23
19.22
19.46
19.70
20.40
23.44
24.12
24.85
25.15
No. of Shareholders
23,886
25,282
25,905
26,657
25,832
24,867
24,891
23,481
22,232
22,137
21,866
21,088
Corporate Actions
22 records
Back to all stocks